Tyrosine is sold in supplement form in nearly every gym, pharmacy, and online health retailer in the United States, marketed for focus, cognitive performance, stress resilience, and athletic output. A large-scale study published in Aging-US and receiving widespread coverage on June 15, 2026 raises an unexpected flag: men with higher circulating tyrosine levels may have lifespans nearly a year shorter than those with lower levels.
The finding does not establish causality, and researchers emphasize that it requires further mechanistic investigation before clinical recommendations change. But it adds a notable complication to the uncritical enthusiasm surrounding one of the supplement industry's most widely used amino acids.
